A Medical Device Daily

Positron (Houston) and Disease Management have agreed to co-develop a coronary artery disease prevention and reversal software program and total disease management solution.

The product will include a heart disease pre-test risk calculator, a Coronary Disease Reversal and Prevention practice management program, a web-based, patient centric, disease reversal and life style modification program, an interpreting and referring physician portal, as well as a cost efficacy and patient outcomes tracker.

"The development of our heart disease management solution will help us reach beyond our current molecular imaging targeted business to offer a product to payers, self insured corporations, multi-specialty groups, cardiology groups, hospitals and finally direct to the consumer," said Joseph Oliverio, president of Positron.

"This is an important step in the growth of our business and the impact on the industry that Positron has been positioning for over the past two years. The product introduction will address a first-to-market opportunity in the Coronary Disease Reversal and Prevention sector, which strengthens Positron's core products that are focused on providing accurate, cost effective imaging and disease management solutions. One of our many goals is to offer even the smallest community hospitals the same level of quality of our most experienced users," Oliverio added.

Positron develops PET scanners.